Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01252511 · ClinicalTrials.gov registry record · NA
Determinants of Fat Malabsorption After Roux-en-Y Gastric Bypass
A NA study, sponsored by Baylor Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01252511 is a NA study that has completed, run by Baylor Research Institute. The registered enrollment target is 20 participants.
The verdict
NCT01252511, a NA study, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether or not the length of the biliopancreatic limb of the Roux-en-Y anastamosis plays a critical role in the development of malabsorption after gastric bypass for treatment of severe obesity.
Interventions
- PROCEDURE RYGB for surgical treatment of severe obesity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-01 |
| Est. Completion | 2017-01-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01252511
The ClinicalTrials.gov registry entry for NCT01252511 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RYGB for surgical treatment of severe obesity is the first listed.
NCT01252511 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01252511 about?
NCT01252511 is a clinical study titled "Determinants of Fat Malabsorption After Roux-en-Y Gastric Bypass". The purpose of this study is to determine whether or not the length of the biliopancreatic limb of the Roux-en-Y anastamosis plays a critical role in the development of malabsorption after gastric bypass for treatment of severe obesity.
What is the current status of trial NCT01252511?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2011-01. Estimated completion is 2017-01-14.
What interventions are being tested in trial NCT01252511?
The interventions under investigation include: RYGB for surgical treatment of severe obesity (PROCEDURE).
Who is sponsoring clinical trial NCT01252511?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.